Search Share Prices
GSK Headlines - What now for the GlaxoSmithKline (LON: GSK) share price?
GlaxoSmithKline reported strong sales growth in the first quarter, but the GSK share price didn't move much in response. Time to buy?
GSK tops quarterly forecasts, helped by COVID-19 treatment and Shingrix
British pharmaceuticals giant GSK beat analyst expectations for its first-quarter results on Wednesday and stood by its 2022 forecasts, after buoyant sales of its COVID-19 treatment which has now been ...
GlaxoSmithKline (LON:GSK) Given a GBX 1,740 Price Target at JPMorgan Chase & Co.
GlaxoSmithKline (LON:GSK – Get Rating) has been assigned a GBX 1,740 ($22.64) target price by investment analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Monday ...
JPMorgan Chase & Co. Analysts Give GlaxoSmithKline (LON:GSK) a GBX 1,740 Price Target
GlaxoSmithKline (LON:GSK – Get Rating) has been assigned a GBX 1,740 ($22.64) price objective by research analysts at JPMorgan Chase & Co. in a report issued on Monday, Borsen Zeitung reports.
GlaxoSmithKline (GSK) Stock Moves -0.33%: What You Should Know
GlaxoSmithKline (GSK) closed the most recent trading day at $45.69, moving -0.33% from the previous trading session. This change was narrower than the S&P 500's daily loss of 1.48%. Elsewhere, the Dow ...